Company | Cap $ | P/E | P/B | P/S | ROE | ROA | ROS | L/A | P/FCF | PR | Period |
---|---|---|---|---|---|---|---|---|---|---|---|
Nikola Corp. | 3,106 | 2021 | |||||||||
Iovance Biotherapeutics | 2,756 | 2023q1 | |||||||||
Passage Bio | 63 | 2023q3 | |||||||||
Bellerophon Therapeutics | 0 | 2021 | |||||||||
Athira Pharma | 97 | 2023q3 | |||||||||
Check-Cap | 182 | 2021 | |||||||||
Quince Therapeutics | 24 | 2021 | |||||||||
Vaxcyte | 3,786 | 2021 | |||||||||
Palo Alto Networks | 85,700 | 2023 | |||||||||
Oric Pharmaceuticals | 560 | 2023q3 | |||||||||
Krystal Biotech | 4,683 | 2023q2 | |||||||||
BioLineRx | 2,070 | 2021 | |||||||||
Rocket Pharmaceuticals | 1,846 | 2023q3 | |||||||||
Xinyuan Real Estate Co | 18 | 2022q2 | |||||||||
Allakos | 121 | 2023q3 | |||||||||
Madrigal Pharmaceuticals | 3,943 | 2023q1 | |||||||||
Gossamer Bio | 130 | 2023q1 | |||||||||
BrainStorm Cell Therapeut... | 21 | 2021 | |||||||||
Citius Pharmaceuticals | 65 | 2023q3 | |||||||||
Fusion Fuel Green | 124 | 2021q1 |